Engage Bio
AcquiredYC W22San Francisco, US · Founded 2021 · 10 employees · 4 known investors
EngageBio develops DNA-based medicines using proprietary non-viral delivery technology to achieve extended therapeutic expression from a single dose with low manufacturing complexity.
BiotechDigital HealthHealthtechSynthetic BiologyHealthcareTherapeuticsDrug discoveryUnited States of AmericaAmerica / Canada
Founders & leadership· Y Combinator alumni (W22)
Engage Bio was founded in 2021 by Will Olsen.
WO
Investors · 4
Funding
SEC filings, press & company announcements- Undisclosed amountSeedJul 2024Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Competitors · 2
by search overlapBridgebio40 shared keywordsBridgeBio develops treatments for genetic conditions and cancers using a decentralized hub-and-spoke model, where autonomous teams focus on specific diseases or drug candidates while a central hub provides clinical, regulatory, and commercial support. The company partners with academic institutions to advance early-stage research toward late-stage clinical trials.
GentiBio31 shared keywordsGentiBio develops engineered regulatory T-cell (EngTreg) therapies designed to reset the immune system and treat autoimmune and acute inflammatory diseases. The company builds autologous and allogeneic Treg platforms as an alternative to systemic immune-suppressive therapies.
Companies competing with Engage Bio for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Engage Bio do?
- EngageBio develops DNA-based medicines using proprietary non-viral delivery technology to achieve extended therapeutic expression from a single dose with low manufacturing complexity.
- Who founded Engage Bio?
- Engage Bio was founded by Will Olsen in 2021.
- Who are Engage Bio's investors?
- Engage Bio's investors include Metaplanet, SciFounders, WorldQuant Ventures, Y Combinator.
- Where is Engage Bio headquartered?
- Engage Bio is headquartered in San Francisco, US.





